Infections and autoimmunity - friends or foes?

Trends in Immunology

Volumn 30, Issue 8, 2009, Pages 409-414

  Kivity, Shaye ^a   Agmon Levin, Nancy ^a   Blank, Miri ^a   Shoenfeld, Yehuda ^a,b  

^a SHEBA MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AUTOIMMUNITY; CONTROLLED STUDY; COXSACKIE VIRUS; ENVIRONMENTAL FACTOR; EPITOPE MAPPING; GENETIC SUSCEPTIBILITY; HYGIENE; INFECTION; MOUSE; NONHUMAN; PLASMODIUM BERGHEI; REGULATORY MECHANISM; REVIEW; SCHISTOSOMA MANSONI;

ANIMALS; AUTOIMMUNE DISEASES; AUTOIMMUNITY; CHILD; CHILD, PRESCHOOL; DISEASE MODELS, ANIMAL; HUMANS; INFECTION; MICE; MICE, INBRED NOD;

EID: 68149091433     PISSN: 14714906     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.it.2009.05.005     Document Type: Review

References (81)

1. Shoenfeld Y., et al. The mosaic of autoimmunity: prediction, autoantibodies, and therapy in autoimmune diseases-2008. Isr. Med. Assoc. J. 10 (2008) 13-19
2. Shoenfeld Y., et al. The mosaic of autoimmunity: genetic factors involved in autoimmune diseases-2008. Isr. Med. Assoc. J. 10 (2008) 3-7
3. Shoenfeld Y., et al. The mosaic of autoimmunity: hormonal and environmental factors involved in autoimmune diseases-2008. Isr. Med. Assoc. J. 10 (2008) 8-12
4. Zandman-Goddard G., et al. Neuropsychiatric lupus and infectious triggers. Lupus 17 (2008) 380-384
5. Barzilai O., et al. Epstein-Barr virus and cytomegalovirus in autoimmune diseases: are they truly notorious? A preliminary report. Ann. N. Y. Acad. Sci. 1108 (2007) 567-577
6. Ram M., et al. The putative protective role of hepatitis B virus (HBV) infection from autoimmune disorders. Autoimmun. Rev. 7 (2008) 621-625
7. Tozzoli R., et al. Infections and autoimmune thyroid diseases: parallel detection of antibodies against pathogens with proteomic technology. Autoimmun. Rev. 8 (2008) 112-115
8. Sherer, Y. et al. Multiple infectious agents screen in antiphospholipid syndrome. Lupus (in press)
9. Lidar, M. et al. Infectious Serologies and Autoantibodies in Wegener's Granulomatosis and other Vasculitides: Novel Associations Disclosed Using the Rad BioPlex 2200. Ann. N. Y. Acad. Sci. (in press)
10. Lidar, M. et al. Infectious serologies and autoantibodies in inflammatory bowel disease: insinuations at a true pathogenic role. Ann. N. Y. Acad. Sci. (in press)
11. Krause, I. et al. Anti-infectious antibodies and autoimmune-associated autoantibodies in patients with type I diabetes mellitus and their close family members. Ann. N. Y. Acad. Sci. (in press)
12. Agmon-Levin N., et al. Prevalence of hepatitis C serum antibody in autoimmune diseases. J. Autoimmun. 32 (2009) 261-266
13. Zandman-Goddard, G. et al. Exposure to Epstein-Barr virus infection is associated with mild SLE disease. Ann. N. Y. Acad. Sci. (in press)
14. Fae K.C., et al. Mimicry in recognition of cardiac myosin peptides by heart-intralesional T cell clones from rheumatic heart disease. J. Immunol. 176 (2006) 5662-5670
15. Blank M., et al. Immunization with anticardiolipin cofactor (beta-2-glycoprotein I) induces experimental antiphospholipid syndrome in naive mice. J. Autoimmun. 7 (1994) 441-455
16. Pierangeli S.S., et al. Thrombogenic properties of murine anti-cardiolipin antibodies induced by beta 2 glycoprotein 1 and human immunoglobulin G antiphospholipid antibodies. Circulation 94 (1996) 1746-1751
17. Blank M., et al. Bacterial induction of autoantibodies to beta2-glycoprotein-I accounts for the infectious etiology of antiphospholipid syndrome. J. Clin. Invest. 109 (2002) 797-804
18. Richardson S.J., et al. The prevalence of enteroviral capsid protein vp1 immunostaining in pancreatic islets in human type 1 diabetes. Diabetologia 52 (2009) 1143-1151
19. Deng G.M., and Tsokos G.C. Cholera toxin B accelerates disease progression in lupus-prone mice by promoting lipid raft aggregation. J. Immunol. 181 (2008) 4019-4026
20. Ka S.M., et al. Mesangial cells of lupus-prone mice are sensitive to chemokine production. Arthritis Res. Ther. 9 (2007) R67
21. Graham K.L., et al. Rotavirus infection accelerates type 1 diabetes in mice with established insulitis. J. Virol. 82 (2008) 6139-6149
22. Chakravarty E.F. Viral infection and reactivation in autoimmune disease. Arthritis Rheum. 58 (2008) 2949-2957
23. Evans A.S., et al. Raised antibody titres to E.B. virus in systemic lupus erythematosus. Lancet 1 (1971) 167-168
24. Poole B.D., et al. Lupus-like autoantibody development in rabbits and mice after immunization with EBNA-1 fragments. J. Autoimmun. 31 (2008) 362-371
25. Kang I., et al. Defective control of latent Epstein-Barr virus infection in systemic lupus erythematosus. J. Immunol. 172 (2004) 1287-1294
26. Selmi C., et al. Primary biliary cirrhosis in monozygotic and dizygotic twins: genetics, epigenetics, and environment. Gastroenterology 127 (2004) 485-492
27. Fairweather D., and Rose N.R. Coxsackievirus-induced myocarditis in mice: a model of autoimmune disease for studying immunotoxicity. Methods 41 (2007) 118-122
28. Neu N., et al. Cardiac myosin induces myocarditis in genetically predisposed mice. J. Immunol. 139 (1987) 3630-3636
29. Kudat H., et al. The role of HLA molecules in susceptibility to chronic rheumatic heart disease. Int. J. Immunogenet. 33 (2006) 41-44
30. Cacoub P., et al. Influence of HLA-DR phenotype on the risk of hepatitis C virus-associated mixed cryoglobulinemia. Arthritis Rheum. 44 (2001) 2118-2124
31. Gran J.T., et al. The association between rheumatoid arthritis and the HLA antigen DR4. Ann. Rheum. Dis. 42 (1983) 292-296
32. Haines J.L., et al. Linkage of the MHC to familial multiple sclerosis suggests genetic heterogeneity. The Multiple Sclerosis Genetics Group. Hum. Mol. Genet. 7 (1998) 1229-1234
33. Graham R.R., et al. Specific combinations of HLA-DR2 and DR3 class II haplotypes contribute graded risk for disease susceptibility and autoantibodies in human SLE. Eur. J. Hum. Genet. 15 (2007) 823-830
34. van der Linden S.M., et al. The risk of developing ankylosing spondylitis in HLA-B27 positive individuals. A comparison of relatives of spondylitis patients with the general population. Arthritis Rheum. 27 (1984) 241-249
35. Wandstrat A., and Wakeland E. The genetics of complex autoimmune diseases: non-MHC susceptibility genes. Nat. Immunol. 2 (2001) 802-809
36. Rioux J.D., and Abbas A.K. Paths to understanding the genetic basis of autoimmune disease. Nature 435 (2005) 584-589
37. Zhang X.J., et al. The genetic concept of vitiligo. J. Dermatol. Sci. 39 (2005) 137-146
38. Stead W.W., et al. Racial differences in susceptibility to infection by Mycobacterium tuberculosis. N. Engl. J. Med. 322 (1990) 422-427
39. Emonts M., et al. Host genetic determinants of Neisseria meningitidis infections. Lancet Infect. Dis. 3 (2003) 565-577
40. Toussirot E., and Roudier J. Epstein-Barr virus in autoimmune diseases. Best Pract. Res. Clin. Rheumatol. 22 (2008) 883-896
41. Annibale B., et al. Two-thirds of atrophic body gastritis patients have evidence of Helicobacter pylori infection. Helicobacter 6 (2001) 225-233
42. D'Elios M.M., et al. Gastric autoimmunity: the role of Helicobacter pylori and molecular mimicry. Trends Mol. Med. 10 (2004) 316-323
43. Tamer G.S., et al. Helicobacter pylori seropositivity in patients with acute coronary syndromes. Dig. Dis. Sci. 54 (2008) 1253-1256
44. Danesh J., et al. Chronic infections and coronary heart disease: is there a link?. Lancet 350 (1997) 430-436
45. Ayada, K. et al. (2008) Chronic infections and atherosclerosis. Clin. Rev. Allergy Immunol. (in press)
46. Gasbarrini A., et al. Vascular and immunological disorders associated with Helicobacter pylori infection. Ital. J. Gastroenterol. Hepatol. 30 (1998) 115-118
47. Amital H., et al. Role of infectious agents in systemic rheumatic diseases. Clin. Exp. Rheumatol. 26 1, Suppl 48 (2008) S27-S32
48. Girones N., et al. Trypanosoma cruzi-induced molecular mimicry and Chagas' disease. Curr. Top. Microbiol. Immunol. 296 (2005) 89-123
49. Arora S., and Huffnagle G.B. Immune regulation during allergic bronchopulmonary mycosis: lessons taught by two fungi. Immunol. Res. 33 (2005) 53-68
50. Guilherme L., et al. Molecular mimicry in the autoimmune pathogenesis of rheumatic heart disease. Autoimmunity 39 (2006) 31-39
51. Kirvan C.A., et al. Mimicry and autoantibody-mediated neuronal cell signaling in Sydenham chorea. Nat. Med. 9 (2003) 914-920
52. Cunningham M.W. Streptococcus-induced myocarditis in mice. Autoimmunity 34 (2001) 193-197
53. Li Y., et al. Mimicry and antibody-mediated cell signaling in autoimmune myocarditis. J. Immunol. 177 (2006) 8234-8240
54. McCarthy N., and Giesecke J. Incidence of Guillain-Barre syndrome following infection with Campylobacter jejuni. Am. J. Epidemiol. 153 (2001) 610-614
55. Godschalk P.C., et al. Structural characterization of Campylobacter jejuni lipooligosaccharide outer cores associated with Guillain-Barre and Miller Fisher syndromes. Infect. Immun. 75 (2007) 1245-1254
56. Yuki N. Infectious origins of, and molecular mimicry in, Guillain-Barre and Fisher syndromes. Lancet Infect. Dis. 1 (2001) 29-37
57. Lehmann P.V., et al. Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen. Nature 358 (1992) 155-157
58. Lehmann P.V., et al. Shifting T-cell activation thresholds in autoimmunity and determinant spreading. Immunol. Rev. 164 (1998) 53-61
59. Karpus W.J., et al. Inhibition of Theiler's virus-mediated demyelination by peripheral immune tolerance induction. J. Immunol. 155 (1995) 947-957
60. Miller S.D., et al. Persistent infection with Theiler's virus leads to CNS autoimmunity via epitope spreading. Nat. Med. 3 (1997) 1133-1136
61. Tuohy V.K., et al. Diversity and plasticity of self recognition during the development of multiple sclerosis. J. Clin. Invest. 99 (1997) 1682-1690
62. Duke R.C. Self recognition by T cells. I. Bystander killing of target cells bearing syngeneic MHC antigens. J. Exp. Med. 170 (1989) 59-71
63. Agmon-Levin N., et al. Prevalence of hepatitis C serum antibody in autoimmune diseases. J. Autoimmun. 54 (2009) 1253-1256
64. Saikku P., et al. Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet 2 (1988) 983-986
65. Zhu J., et al. Effects of total pathogen burden on coronary artery disease risk and C-reactive protein levels. Am. J. Cardiol. 85 (2000) 140-146
66. Andrie R., et al. Z. Kardiol 92 (2003) 641-649
67. Arbuckle M.R., et al. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N. Engl. J. Med. 349 (2003) 1526-1533
68. Carlens C., et al. Perinatal characteristics, early life infections, and later risk of rheumatoid arthritis and juvenile idiopathic arthritis. Ann. Rheum. Dis. 68 (2008) 1159-1164
69. Edwards C.J., et al. Infections in infancy and the presence of antinuclear antibodies in adult life. Lupus 15 (2006) 213-217
70. Edwards C.J., et al. The presence of anticardiolipin antibodies in adults may be influenced by infections in infancy. QJM 101 (2008) 41-47
71. Strachan D.P. Hay fever, hygiene, and household size. BMJ 299 (1989) 1259-1260
72. Gale E.A. The rise of childhood type 1 diabetes in the 20th century. Diabetes 51 (2002) 3353-3361
73. Pugliatti M., et al. The worldwide prevalence of multiple sclerosis. Clin. Neurol. Neurosurg. 104 (2002) 182-191
74. Farrokhyar F., et al. A critical review of epidemiological studies in inflammatory bowel disease. Scand. J. Gastroenterol. 36 (2001) 2-15
75. Zaccone P., et al. Schistosoma mansoni antigens modulate the activity of the innate immune response and prevent onset of type 1 diabetes. Eur. J. Immunol. 33 (2003) 1439-1449
76. Tracy S., et al. Toward testing the hypothesis that group B coxsackieviruses (CVB) trigger insulin-dependent diabetes: inoculating nonobese diabetic mice with CVB markedly lowers diabetes incidence. J. Virol. 76 (2002) 12097-12111
77. Butcher G. Autoimmunity and malaria. Trends Parasitol. 24 (2008) 291-292
78. Greenwood B.M. Autoimmune disease and parasitic infections in Nigerians. Lancet 2 (1968) 380-382
79. Leibowitz U., et al. Epidemiological study of multiple sclerosis in Israel. II. Multiple sclerosis and level of sanitation. J. Neurol. Neurosurg. Psychiatry 29 (1966) 60-68
80. McKinney P.A., et al. Early social mixing and childhood Type 1 diabetes mellitus: a case-control study in Yorkshire, UK. Diabet. Med. 17 (2000) 236-242
81. Vare P.O., et al. Seroprevalence of Helicobacter pylori infection in inflammatory bowel disease: is Helicobacter pylori infection a protective factor?. Scand. J. Gastroenterol. 36 (2001) 1295-1300